Corpus ID: 16025449

focusing on the design and optimization of a large scale biopharmaceutical facility using process simulation and scheduling tools . Design and Optimization of a Large Scale Biopharmaceutical Facility Using Process Simulation and Scheduling Tools by

@inproceedings{Toumi2010focusingOT,
  title={focusing on the design and optimization of a large scale biopharmaceutical facility using process simulation and scheduling tools . Design and Optimization of a Large Scale Biopharmaceutical Facility Using Process Simulation and Scheduling Tools by},
  author={A. Toumi and C. J{\"u}rgens and C. Jungo and B. Maier and Victor Papavasileiou and D. Petrides},
  year={2010}
}
  • A. Toumi, C. Jürgens, +3 authors D. Petrides
  • Published 2010
  • Introduction The global competition in the biopharmaceutical industry and the increased demand for affordable and effective medicines has shifted the industry’s focus on manufacturing efficiency. Therefore, process development and design are gaining importance. For new products, it is crucial to minimize market entry time without compromising product and process quality. This is particularly true for biopharmaceuticals for which it is commonly said that “the process makes the product” and… CONTINUE READING
    6 Citations

    Figures from this paper

    References

    SHOWING 1-10 OF 11 REFERENCES
    The role of process simulation and scheduling tools in the development and manufacturing of biopharmaceuticals
    • 14
    • PDF
    Established bioprocesses for producing antibodies as a basis for future planning.
    • S. Farid
    • Biology, Medicine
    • Advances in biochemical engineering/biotechnology
    • 2006
    • 60
    The therapeutic antibodies market to 2008.
    • Alex K. Pavlou, Mark J. Belsey
    • Business, Medicine
    • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
    • 2005
    • 144
    Biopharmaceutical benchmarks
    • G. Walsh
    • Medicine
    • Nature Biotechnology
    • 2000
    • 543
    Biopharmaceutical benchmarks 2006
    • G. Walsh
    • Engineering, Medicine
    • Nature Biotechnology
    • 2006
    • 332
    Future of Antibody Production,
    • Journal of Chromatography, B
    • 2007